Loading provider…
Loading provider…
Hematology & Oncology Physician in Minneapolis, MN
NPI: 1073579504Primary Practice Location
M HEALTH FAIRVIEW SOUTHDALE HOSPITAL
6401 France Ave S, Edina, MN
Primary Employer
M Health Fairview Heart Clinic
fairview.org
HQ Phone
Get M.D. David's Phone Numberphone_androidMobile
Get M.D. David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIN State Medical License
MN State Medical License
CA State Medical License
1988
MN State Medical License
2006 - 2026
IN State Medical License
2000 - 2007

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Tufts Medical Center
Fellowship • Hematology and Medical Oncology
1992 - 1993
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
Fellowship • Hematology and Medical Oncology
1989 - 1992
Stanford Health Care-Sponsored Stanford University
Residency • Internal Medicine
1986 - 1988
The Johns Hopkins University School of Medicine
hopkinsmedicine.org
Medical School
Until 1982
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 47 | 77 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 19 | 45 |
Authors: Richard Goldstein, Zoltan Erdos
Journal: Birth Defects Res B Dev Reprod Toxicol
Publication Date: 2013-01-30
The influences of patient characteristics and physician experience on case recall.
Authors: Durante, R., McKinlay, J. B., Kasten, L., Potter, D. A.
Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer
Authors: Sunil Badve, George Sledge
Journal: Clin Cancer Res
Lead Sponsor: Masonic Cancer Center, University of Minnesota
Collaborators: Susan G. Komen Breast Cancer Foundation
Intervention / Treatment: PROCEDURE: therapeutic conventional surgery, DRUG: ritonavir
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: Sapanisertib, DRUG: Fulvestrant